DAE HWA Pharmaceutical Co., Ltd.

A067080

KR7067080002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
10,690 ^KRW	-2.82%		+3.69%	+13.97%

2022	DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index	CI
2019	Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.	CI

DAE HWA Pharmaceutical Co., Ltd. authorizes a Buyback Plan.

August 05, 2019

The Board of Directors of DAE HWA Pharmaceutical Co., Ltd. has authorized a buyback plan on August 6, 2019.

Latest news about DAE HWA Pharmaceutical Co., Ltd.

DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) dropped from S&P Global BMI Index	22-09-19	CI
Mediforum Co.,Ltd. acquired 13.9% stake in C-TRI Co., Ltd. from DAE HWA Pharmaceutical Co., Ltd. and Wanjoo Kim for KRW 20.2 billion.	19-12-04	CI
DAE HWA Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 6, 2019, has expired.	19-11-05	CI
DAE HWA Pharmaceutical Co., Ltd. announces an Equity Buyback for 360,000 shares.	19-08-06	CI
DAE HWA Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	19-08-05	CI
DAE HWA Pharmaceutical Co., Ltd. announced that it has received KRW 20 billion in funding	19-03-28	CI
DAE HWA Pharmaceutical Co., Ltd. announced that it expects to receive KRW 20 billion in funding	19-03-27	CI
Shanghai Haihe Biopharma Co., Ltd. announced that it has received $146.6 million in funding from a group of investors	19-02-10	CI
DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	15-12-01	CI
DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to S&P Global BMI Index	15-09-21	CI
DAE HWA Pharmaceutical Co., Ltd.(KOSDAQ:A067080) added to Russell Global Index	15-06-29	CI
DAE HWA Pharmaceutical Co., Ltd. cancelled the acquisition of REDOXBIL CO.,LTD.	14-07-31	CI
DAE HWA Pharmaceutical Co., Ltd. agreed to acquire REDOXBIL CO.,LTD. for KRW 1.1 billion.	13-07-31	CI
Dae Hwa Pharmaceutical Co., Ltd Proposes Dividend	13-02-27	CI

Chart DAE HWA Pharmaceutical Co., Ltd.

Duration

Period

More charts

DAE HWA PHARM CO.,LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include skeletal muscle relaxants, gastro-intestinal drugs, corticosteroids, antihistamines, cardiovascular drugs, drugs for liver diseases, vitamins, tonics, antibiotics, injections, topical drugs, anti-inflammatory enzymes, analgesics, antipyretics, plaster, cough suppressants, expectorants and mucolytics, drugs for hemorrhoid disease and other prescription drugs, as well as over-the-counter (OTC) drugs. The Company distributes its products within domestic market and to overseas markets. On August 22, 2013, it acquired a certain shares of a Korea-based company, which is mainly engaged in the manufacture of medicine raw materials and development of medical devices. After the transaction, the Company held a 100% stake of the Korea-based company.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
DAE HWA PHARMACEUTICAL CO., LTD.	+13.97%	136M
MERCK KGAA	+3.75%	70.44B
KYOWA KIRIN CO. LTD.	+10.97%	8.94B
SK BIOPHARMACEUTICALS CO., LTD.	-16.83%	4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43.48%	4.5B
YUHAN CORPORATION	+3.20%	3.85B
BETTA PHARMACEUTICALS CO., LTD.	-21.36%	2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-29.67%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8.38%	1.96B
SUPERNUS PHARMACEUTICALS, INC.	+3.90%	1.65B

Specialty & Advanced Pharmaceuticals